Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 4
1963 3
1964 2
1965 5
1966 2
1967 2
1968 1
1969 3
1970 1
1971 8
1972 5
1973 4
1974 7
1975 13
1976 8
1977 4
1978 4
1979 6
1980 7
1981 2
1982 2
1983 5
1985 1
1986 2
1987 1
1988 1
1991 3
1992 3
1993 10
1994 1
1996 2
1999 2
2000 2
2001 18
2002 4
2003 12
2004 3
2005 6
2006 5
2007 7
2008 3
2009 4
2010 6
2011 3
2012 2
2013 1
2015 2
2017 1
2018 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
Cancer consequences of the Chernobyl accident in Europe outside the former USSR: a review.
Sali D, Cardis E, Sztanyik L, Auvinen A, Bairakova A, Dontas N, Grosche B, Kerekes A, Kusic Z, Kusoglu C, Lechpammer S, Lyra M, Michaelis J, Petridou E, Szybinski Z, Tominaga S, Tulbure R, Turnbull A, Valerianova Z. Sali D, et al. Among authors: szybinski z. Int J Cancer. 1996 Jul 29;67(3):343-52. doi: 10.1002/(SICI)1097-0215(19960729)67:3<343::AID-IJC7>3.0.CO;2-R. Int J Cancer. 1996. PMID: 8707407 Free article. Review.
[Endothelin--new mediator or hormone?].
Szybiński Z. Szybiński Z. Endokrynol Pol. 1992;43(1):1-6. Endokrynol Pol. 1992. PMID: 1345520 Polish. No abstract available.
Determinants of weight outcomes in type 2 diabetes prevention intervention in primary health care setting (the DE-PLAN project).
Gilis-Januszewska A, Piwońska-Solska B, Lindström J, Wójtowicz E, Tuomilehto J, Schwarz PEH, Kissimova-Skarbek K, Szybiński Z, Windak A, Hubalewska-Dydejczyk A. Gilis-Januszewska A, et al. Among authors: szybinski z. BMC Public Health. 2018 Jan 2;18(1):97. doi: 10.1186/s12889-017-4977-1. BMC Public Health. 2018. PMID: 29291708 Free PMC article. Clinical Trial.
Effectiveness of the iodine prophylaxis model adopted in Poland.
Szybinski Z, Golkowski F, Buziak-Bereza M, Trofimiuk M, Przybylik-Mazurek E, Huszno B, Bandurska-Stankiewicz E, Bar-Andziak E, Dorant B, Kinalska I, Lewinski A, Klencki M, Rybakowa M, Sowinski J, Szewczyk L, Szponar L, Wasik R. Szybinski Z, et al. J Endocrinol Invest. 2008 Apr;31(4):309-13. doi: 10.1007/BF03346363. J Endocrinol Invest. 2008. PMID: 18475048
205 results